{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:50:28Z","timestamp":1782201028129,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,23]]},"DOI":"10.7759\/cureus.111337","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:31:54Z","timestamp":1782199914000},"source":"Crossref","is-referenced-by-count":0,"title":["AI-Assisted Chemotherapy Regimen Selection and Its Effects on Clinical Outcomes and Adverse Drug Reactions: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Abhishek","family":"Vadher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Baraiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbadi Gajendra","family":"Siva Krishna Pavan Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utsav R","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmadmahikhan F","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Kambhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faizkhan F","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Kambhatla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.5561","article-title":"Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline","volume":"34","author":"Balaban EP","year":"2016","unstructured":"Balaban EP, Mangu PB, Khorana AA, et al.. Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2016, 34:2654-2668. 10.1200\/JCO.2016.67.5561","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612613","article-title":"The future of precision oncology","volume":"24","author":"Rulten SL","year":"2023","unstructured":"Rulten SL, Grose RP, Gatz SA, Jones JL, Cameron AJ. The future of precision oncology. Int J Mol Sci. 2023, 24:12613. 10.3390\/ijms241612613","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05067-0","article-title":"Tribulations and future opportunities for artificial intelligence in precision medicine","volume":"22","author":"Carini C","year":"2024","unstructured":"Carini C, Seyhan AA. Tribulations and future opportunities for artificial intelligence in precision medicine. J Transl Med. 2024, 22:411. 10.1186\/s12967-024-05067-0","journal-title":"J Transl Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01177","article-title":"Artificial intelligence to decode cancer mechanism: beyond patient stratification for precision oncology","volume":"11","author":"Patel SK","year":"2020","unstructured":"Patel SK, George B, Rai V. Artificial intelligence to decode cancer mechanism: beyond patient stratification for precision oncology. Front Pharmacol. 2020, 11:1177. 10.3389\/fphar.2020.01177","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-021-00216-w","article-title":"Artificial intelligence for the next generation of precision oncology","volume":"5","author":"Ballester PJ","year":"2021","unstructured":"Ballester PJ, Carmona J. Artificial intelligence for the next generation of precision oncology. NPJ Precis Oncol. 2021, 5:79. 10.1038\/s41698-021-00216-w","journal-title":"NPJ Precis Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1475893","article-title":"Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook","volume":"15","author":"Abdul Rasool Hassan B","year":"2025","unstructured":"Abdul Rasool Hassan B, Mohammed AH, Hallit S, Malaeb D, Hosseini H. Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook. Front Oncol. 2025, 15:1475893. 10.3389\/fonc.2025.1475893","journal-title":"Front Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-22-0373","article-title":"Artificial intelligence and machine learning technologies in cancer care: addressing disparities, bias, and data diversity","volume":"12","author":"Dankwa-Mullan I","year":"2022","unstructured":"Dankwa-Mullan I, Weeraratne D. Artificial intelligence and machine learning technologies in cancer care: addressing disparities, bias, and data diversity. Cancer Discov. 2022, 12:1423-1427. 10.1158\/2159-8290.CD-22-0373","journal-title":"Cancer Discov"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1109\/RBME.2025.3577587","article-title":"Advancing precision oncology through modeling of longitudinal and multimodal data","volume":"19","author":"Zhuang L","year":"2026","unstructured":"Zhuang L, Park SH, Skates SJ, Prosper AE, Aberle DR, Hsu W. Advancing precision oncology through modeling of longitudinal and multimodal data. IEEE Rev Biomed Eng. 2026, 19:182-200. 10.1109\/RBME.2025.3577587","journal-title":"IEEE Rev Biomed Eng"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12909-023-04698-z","article-title":"Revolutionizing healthcare: the role of artificial intelligence in clinical practice","volume":"23","author":"Alowais SA","year":"2023","unstructured":"Alowais SA, Alghamdi SS, Alsuhebany N, et al.. Revolutionizing healthcare: the role of artificial intelligence in clinical practice. BMC Med Educ. 2023, 23:689. 10.1186\/s12909-023-04698-z","journal-title":"BMC Med Educ"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons KG","year":"2025","unstructured":"Moons KG, Damen JA, Kaul T, et al.. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods. BMJ. 2025, 388:e082505. 10.1136\/bmj-2024-082505","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-3327","article-title":"A computational pathology model to predict docetaxel benefit in localized high-risk and metastatic prostate cancer","volume":"32","author":"Medina S","year":"2026","unstructured":"Medina S, Tokuyama N, Hammouda K, et al.. A computational pathology model to predict docetaxel benefit in localized high-risk and metastatic prostate cancer. Clin Cancer Res. 2026, 32:645-653. 10.1158\/1078-0432.CCR-25-3327","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-023-07237-y","article-title":"Deep learning-guided adjuvant chemotherapy selection for elderly patients with breast cancer","volume":"205","author":"Zhu E","year":"2024","unstructured":"Zhu E, Zhang L, Wang J, et al.. Deep learning-guided adjuvant chemotherapy selection for elderly patients with breast cancer. Breast Cancer Res Treat. 2024, 205:97-107. 10.1007\/s10549-023-07237-y","journal-title":"Breast Cancer Res Treat"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03459-8","article-title":"Determining individual suitability for neoadjuvant systemic therapy in breast cancer patients through deep learning","volume":"26","author":"Zhu E","year":"2024","unstructured":"Zhu E, Zhang L, Liu Y, et al.. Determining individual suitability for neoadjuvant systemic therapy in breast cancer patients through deep learning. Clin Transl Oncol. 2024, 26:2584-2593. 10.1007\/s12094-024-03459-8","journal-title":"Clin Transl Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-25-02199","article-title":"Development and validation of a computational histology artificial intelligence-powered predictive biomarker for selection of chemotherapy in advanced pancreatic cancer","author":"Hendifar AE","year":"2026","unstructured":"Hendifar AE, Krishna V, Krishna V, et al.. Development and validation of a computational histology artificial intelligence-powered predictive biomarker for selection of chemotherapy in advanced pancreatic cancer. J Clin Oncol. 2026, JCO2502199. 10.1200\/JCO-25-02199","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.06.010","article-title":"Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma","volume":"35","author":"Fraunhoffer N","year":"2024","unstructured":"Fraunhoffer N, Hammel P, Conroy T, et al.. Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma. Ann Oncol. 2024, 35:780-791. 10.1016\/j.annonc.2024.06.010","journal-title":"Ann Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.25881","article-title":"Machine learning-guided adjuvant treatment of head and neck cancer","volume":"3","author":"Howard FM","year":"2020","unstructured":"Howard FM, Kochanny S, Koshy M, Spiotto M, Pearson AT. Machine learning-guided adjuvant treatment of head and neck cancer. JAMA Netw Open. 2020, 3:e2025881. 10.1001\/jamanetworkopen.2020.25881","journal-title":"JAMA Netw Open"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61823-w","article-title":"Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC","volume":"16","author":"Saad MB","year":"2025","unstructured":"Saad MB, Al-Tashi Q, Hong L, et al.. Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC. Nat Commun. 2025, 16:6828. 10.1038\/s41467-025-61823-w","journal-title":"Nat Commun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2196\/29455","article-title":"Optimal treatment selection in sequential systemic and locoregional therapy of oropharyngeal squamous carcinomas: deep Q-learning with a patient-physician digital twin dyad","volume":"24","author":"Tardini E","year":"2022","unstructured":"Tardini E, Zhang X, Canahuate G, et al.. Optimal treatment selection in sequential systemic and locoregional therapy of oropharyngeal squamous carcinomas: deep Q-learning with a patient-physician digital twin dyad. J Med Internet Res. 2022, 24:e29455. 10.2196\/29455","journal-title":"J Med Internet Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1326591","article-title":"Optimizing adjuvant treatment options for patients with glioblastoma","volume":"15","author":"Zhu E","year":"2024","unstructured":"Zhu E, Wang J, Shi W, Jing Q, Ai P, Shan D, Ai Z. Optimizing adjuvant treatment options for patients with glioblastoma. Front Neurol. 2024, 15:1326591. 10.3389\/fneur.2024.1326591","journal-title":"Front Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/srep43294","article-title":"Personalized chemotherapy selection for breast cancer using gene expression profiles","volume":"7","author":"Yu K","year":"2017","unstructured":"Yu K, Sang QA, Lung PY, et al.. Personalized chemotherapy selection for breast cancer using gene expression profiles. Sci Rep. 2017, 7:43294. 10.1038\/srep43294","journal-title":"Sci Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1418800","article-title":"Personalized chemotherapy selection for patients with triple-negative breast cancer using deep learning","volume":"11","author":"Yang X","year":"2024","unstructured":"Yang X, Vladmirovich RI, Georgievna PM, et al.. Personalized chemotherapy selection for patients with triple-negative breast cancer using deep learning. Front Med (Lausanne). 2024, 11:1418800. 10.3389\/fmed.2024.1418800","journal-title":"Front Med (Lausanne)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S532116","article-title":"Refining intra-arterial therapy selection for large hepatocellular carcinoma: a deep learning approach based on covariate interaction analysis","volume":"12","author":"An C","year":"2025","unstructured":"An C, Li L, Luo Y, Zuo M, Liu W, Li C, Wu P. Refining intra-arterial therapy selection for large hepatocellular carcinoma: a deep learning approach based on covariate interaction analysis. J Hepatocell Carcinoma. 2025, 12:1393-1405. 10.2147\/JHC.S532116","journal-title":"J Hepatocell Carcinoma"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-025-01918-2","article-title":"Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma","volume":"8","author":"Liu Y","year":"2025","unstructured":"Liu Y, Yan W, Chen Y, et al.. Treatment response-adapted risk index model for survival prediction and adjuvant chemotherapy selection in nonmetastatic nasopharyngeal carcinoma. NPJ Digit Med. 2025, 8:564. 10.1038\/s41746-025-01918-2","journal-title":"NPJ Digit Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.54254\/2755-2721\/2026.31509","article-title":"Deep learning-based prediction and optimization of histone methylation-oxidative stress networks in doxorubicin-induced cardiomyopathy","volume":"219","author":"Wang Y","year":"2026","unstructured":"Wang Y. Deep learning-based prediction and optimization of histone methylation-oxidative stress networks in doxorubicin-induced cardiomyopathy. Appl Comput Eng. 2026, 219:106-112. 10.54254\/2755-2721\/2026.31509","journal-title":"Appl Comput Eng"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2025-6214","article-title":"Evaluating artificial intelligence (AI) as a clinical decision support tool for AML patients","volume":"146","author":"Sanghvi A","year":"2025","unstructured":"Sanghvi A, Adhikari N, Chowdhry V, et al.. Evaluating artificial intelligence (AI) as a clinical decision support tool for AML patients. Blood. 2025, 146:6214. 10.1182\/blood-2025-6214","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0090","article-title":"Artificial intelligence in cancer research and precision medicine","volume":"11","author":"Bhinder B","year":"2021","unstructured":"Bhinder B, Gilvary C, Madhukar NS, Elemento O. Artificial intelligence in cancer research and precision medicine. Cancer Discov. 2021, 11:900-915. 10.1158\/2159-8290.CD-21-0090","journal-title":"Cancer Discov"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1034-x","article-title":"Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension","volume":"26","author":"Liu X","year":"2020","unstructured":"Liu X, Cruz RS, Moher D, Calvert MJ, Denniston AK. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat Med. 2020, 26:1364-1374. 10.1038\/s41591-020-1034-x","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3210","article-title":"Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension","volume":"370","author":"Rivera SC","year":"2020","unstructured":"Rivera SC, Liu X, Chan AW, Denniston AK, Calvert MJ. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension. BMJ. 2020, 370:m3210. 10.1136\/bmj.m3210","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01772-9","article-title":"Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI","volume":"28","author":"Vasey B","year":"2022","unstructured":"Vasey B, Nagendran M, Campbell B, et al.. Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nat Med. 2022, 28:924-933. 10.1038\/s41591-022-01772-9","journal-title":"Nat Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00835-7","article-title":"Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial","volume":"9","author":"Blasiak A","year":"2025","unstructured":"Blasiak A, Truong AT, Foo N, et al.. Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial. NPJ Precis Oncol. 2025, 9:49. 10.1038\/s41698-025-00835-7","journal-title":"NPJ Precis Oncol"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer","volume":"25","author":"Kather JN","year":"2019","unstructured":"Kather JN, Pearson AT, Halama N, et al.. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med. 2019, 25:1054-1056.","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol EJ","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019, 25:44-56. 10.1038\/s41591-018-0300-7","journal-title":"Nat Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1038\/520609a","article-title":"Personalized medicine: time for one-person trials","volume":"520","author":"Schork NJ","year":"2015","unstructured":"Schork NJ. Personalized medicine: time for one-person trials. Nature. 2015, 520:609-611. 10.1038\/520609a","journal-title":"Nature"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-025-00991-6","article-title":"Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology","volume":"6","author":"Ferber D","year":"2025","unstructured":"Ferber D, El Nahhas OS, W\u00f6lflein G, et al.. Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology. Nat Cancer. 2025, 6:1337-1349. 10.1038\/s43018-025-00991-6","journal-title":"Nat Cancer"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101064","article-title":"Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice","volume":"46","author":"Verlingue L","year":"2024","unstructured":"Verlingue L, Boyer C, Olgiati L, Brutti Mairesse C, Morel D, Blay JY. Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice. Lancet Reg Health Eur. 2024, 46:101064. 10.1016\/j.lanepe.2024.101064","journal-title":"Lancet Reg Health Eur"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/aira2401164","article-title":"The use of artificial intelligence for cancer therapeutic decision-making","volume":"2","author":"Elemento O","year":"2025","unstructured":"Elemento O, Khozin S, Sternberg CN. The use of artificial intelligence for cancer therapeutic decision-making. NEJM AI. 2025, 2:10.1056\/aira2401164","journal-title":"NEJM AI"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins GS","year":"2024","unstructured":"Collins GS, Moons KG, Dhiman P, et al.. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024, 385:e078378. 10.1136\/bmj-2023-078378","journal-title":"BMJ"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff RF","year":"2019","unstructured":"Wolff RF, Moons KG, Riley RD, et al.. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019, 170:51-58. 10.7326\/M18-1376","journal-title":"Ann Intern Med"},{"key":"ref39","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons KM","year":"2025","unstructured":"Moons KM, Damen JA, Kaul T, et al.. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods. BMJ. 2025, 388:e082505.","journal-title":"BMJ"},{"key":"ref40","unstructured":"U.S. Food and Drug Administration. Good Machine Learning Practice for Medical Device Development. Guiding Principles. (2025). Accessed: December 19, 2025: https:\/\/www.fda.gov\/medical-devices\/software-medical-device-samd\/good-machine-learning-practice-medical-device-develo...."},{"key":"ref41","unstructured":"International Medical Device Regulators Forum. Software as a Medical Device (SaMD). Clinical Evaluation. IMDRF\/SaMD WG\/N41FINAL:2017. (2017). Accessed: September 21, 2017: https:\/\/www.imdrf.org\/documents\/software-medical-device-samd-clinical-evaluation."},{"key":"ref42","unstructured":"World Health Organization. Ethics and governance of artificial intelligence for health. WHO guidance. Geneva: World Health Organization. (2021). https:\/\/www.who.int\/publications\/i\/item\/9789240029200."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/494676-ai-assisted-chemotherapy-regimen-selection-and-its-effects-on-clinical-outcomes-and-adverse-drug-reactions-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:32:02Z","timestamp":1782199922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/494676-ai-assisted-chemotherapy-regimen-selection-and-its-effects-on-clinical-outcomes-and-adverse-drug-reactions-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.111337","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}